US Patent 10603353 Recombinant clostridial neurotoxins with increased duration of effect

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Merz Pharma

Current Assignee

Merz Pharma

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10603353

Date of Patent

March 31, 2020

Patent Application Number

15735417

Date Filed

June 10, 2016

Patent Citations

‌

US Patent 10022424 Use of gelsolin to treat infections

Patent Citations Received

‌

US Patent 11357821 Recombinant clostridial neurotoxins with increased duration of effect

Patent Primary Examiner

‌

Nita M. Minnifield

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10603353 Recombinant clostridial neurotoxins with increased duration of effect

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API